4//SEC Filing
Lingamneni Anila 4
Accession 0001127602-22-014984
CIK 0000313143other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:57 PM ET
Size
7.2 KB
Accession
0001127602-22-014984
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Award
Common Stock
2022-05-16+4,340→ 18,706 total - Award
Non-qualified Stock Option (Right to Buy)
2022-05-16+10,148→ 10,148 totalExercise: $57.60Exp: 2029-05-16→ Common Stock (10,148 underlying)
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported as well as 353 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 29, 2022.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001808414
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:57 PM ET
- Size
- 7.2 KB